Log in | Register

The effect of high-dose cholecalciferol on bioavailable vitamin D levels in critically ill patients: a post hoc analysis of the VITdAL-ICU trial

Gennaro Martucci| Fabio Tuzzolino| Antonio Arcadipane| Thomas R. Pieber| Christian Schnedl| Tadeja Urbanic Purkart| Gerlies Treiber| Karin Amrein
Volume 43, Issue 11 / November , 2017

Pages 1732 - 1734

No abstract available.


  1. Amrein K, Christopher KB, McNally JD (2015) Understanding vitamin D deficiency in intensive care patients. Intensive Care Med 41:1961–1964
  2. McNally JD, Ginde AA, Amrein K (2017) Clarification needed for the systematic review of vitamin D trials in the ICU. Intensive Care Med 43(4):595–596
  3. Quraishi SA, De Pascale G, Needleman JS, Nakazawa H, Kaneki M, Bajwa EK, Camargo CA Jr, Bhan I (2015) Effect of cholecalciferol supplementation on vitamin D status and cathelicidin levels in sepsis: a randomized, placebo-controlled trial. Crit Care Med 43:1928–1937
    • View reference on publisher's website
    • View reference on PubMed
  4. Nielson CM, Jones KS, Bouillon R, Chun RF, Jacobs J, Wang Y, Hewison M, Adams JS, Swanson CM, Lee CG, Vanderschueren D, Pauwels S, Prentice A, Smith RD, Shi T, Gao Y, Zmuda JM, Lapidus J, Cauley JA, Schoenmakers I, Orwoll ES (2016) Role of assay type in determining free 25-hydroxyvitamin D levels in diverse populations. N Engl J Med 374:1695–1696
    • View reference on publisher's website
    • View reference on PubMed
  5. Amrein K, Schnedl C, Holl A, Riedl R, Christopher KB, Pachler C, Urbanic Purkart T, Waltensdorfer A, Munch A, Warnkross H, Stojakovic T, Bisping E, Toller W, Smolle KH, Berghold A, Pieber TR, Dobnig H (2014) Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. JAMA 312:1520–1530
    • View reference on publisher's website
    • View reference on PubMed

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement